Detalhe da pesquisa
1.
A Phase 2A Trial of the Safety and Tolerability of Increased Dose Rifampicin and Adjunctive Linezolid, With or Without Aspirin, for Human Immunodeficiency Virus-Associated Tuberculous Meningitis: The LASER-TBM Trial.
Clin Infect Dis
; 76(8): 1412-1422, 2023 04 17.
Artigo
Inglês
| MEDLINE | ID: mdl-36482216
2.
Plasma Pharmacokinetics of High-Dose Oral versus Intravenous Rifampicin in Patients with Tuberculous Meningitis: a Randomized Controlled Trial.
Antimicrob Agents Chemother
; 65(8): e0014021, 2021 07 16.
Artigo
Inglês
| MEDLINE | ID: mdl-33972248
3.
Blood cultures taken from patients attending emergency departments in South Africa are an important antibiotic stewardship tool, which directly influences patient management.
BMC Infect Dis
; 15: 410, 2015 Oct 06.
Artigo
Inglês
| MEDLINE | ID: mdl-26437651
4.
Testing novel strategies for patients hospitalised with HIV-associated disseminated tuberculosis (NewStrat-TB): protocol for a randomised controlled trial.
Trials
; 25(1): 311, 2024 May 08.
Artigo
Inglês
| MEDLINE | ID: mdl-38720383
5.
Convalescent plasma in the treatment of moderate to severe COVID-19 pneumonia: a randomized controlled trial (PROTECT-Patient Trial).
Sci Rep
; 12(1): 2552, 2022 02 15.
Artigo
Inglês
| MEDLINE | ID: mdl-35169169
6.
Study protocol for a phase 2A trial of the safety and tolerability of increased dose rifampicin and adjunctive linezolid, with or without aspirin, for HIV-associated tuberculous meningitis [LASER-TBM].
Wellcome Open Res
; 6: 136, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-34286103